For weight loss that may have stalled on tirzepatide, the resources about plateaus on GLP-1 therapy provide useful framing that applies regardless of which specific compound is involved
[7] In a Bayesian network meta-analysis of 48 randomized trials and nearly 28,000 participants, the dominant gastrointestinal events were nausea (about 21.5%), diarrhea (10.6%), vomiting (9.1%), and constipation (7.9%), with semaglutide carrying one of the highest constipation risks
25 mg tablets: pale yellow, oval, biconvex film-coated tablets, debossed with "S 25" on one side and the Boehringer Ingelheim company symbol on the other side
The body needs approximately 2 to 3 weeks to adapt to each new dose level, so if you are increasing every 4 weeks (as most protocols recommend), you may feel like the symptoms are constant during this phase
Diabetes and Cancer